Market Place
Sourcing Support
Alliance Pharma and Drug Development Solutions Are Now Resolian
17 May 2023 //
BUSINESSWIRE
Alliance Pharma unveils state-of-the-art bioanalytical laboratory in Brisbane
08 Dec 2022 //
BIOSPECTRUMASIA
Alliance Pharma Opens State-of-the-Art Bioanalytical Laboratory in Brisbane
07 Dec 2022 //
BUSINESSWIRE
Alliance growth continues with debut of a new testing lab
07 Dec 2022 //
FIERCEBIOTECH
Alliance Pharma Opens Bioanalytical Lab in Brisbane
07 Dec 2022 //
CONTRACTPHARMA
Alliance Pharma names 4 to C-suite positions amid expansion
22 Sep 2022 //
FIERCEBIOTECH
Alliance Pharma Expands Leadership Team
21 Sep 2022 //
CONTRACTPHARMA
Alliance Pharma’s Executive Team Grows by Four
21 Sep 2022 //
BUSINESSWIRE
Alliance Pharma boss faces disqualification after CMA probe
02 Sep 2022 //
YAHOO
U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia
11 Aug 2022 //
BUSINESSWIRE
U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business
13 Jul 2022 //
PRESS RELEASE
Alliance Pharma to acquire LGC`s Drug Development Solutions Business
17 May 2022 //
PRNEWSWIRE
Alliance Pharma Appoints Patrick Bennett as Chief Executive Officer
11 Apr 2022 //
PRNEWSWIRE
Class 4 Medicine Defect Information: Xonvea 10 mg/10 mg gastro-resistant tablets
17 Oct 2019 //
MHRA
Alliance Pharma unveils big board reshuffle with deputy CEO to become CEO
28 Feb 2018 //
PROACTIVEINVESTOR
Patients at risk in Brexit negotiations, warns Alliance
01 Aug 2017 //
PHARMA TIMES
Express Scripts drops coverage of Valeant diabetes drug Glumetza
30 Jan 2016 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.